HB-64

N/A

Report date: 2023/02/11 20:38:37
NME

Base Information

Drug NameHB-64
Drug Alias NameHB-64
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAcne Vulgaris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHelix Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHelix Biopharma
Active IndicationsN/A
Inactive IndicationsAcne Vulgaris

Other Information

ATC CodeN/A
Related LinksN/A